Erlotinib monotherapy in patients with advanced non-small cell lung cancer: an effective approach with low toxicity.

scientific article published in July 2008

Erlotinib monotherapy in patients with advanced non-small cell lung cancer: an effective approach with low toxicity. is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID18751427

P2093author name stringAndreas Scorilas
Alexandros Ardavanis
Ioannis Mantzaris
Savvoula Malliou
Gerassimos Rigatos
Ioannis Fragos
Flora Kyriakou
Stella Koumna
P433issue4C
P407language of work or nameEnglishQ1860
P921main subjecterlotinibQ418369
P304page(s)2409-2415
P577publication date2008-07-01
P1433published inAnticancer ResearchQ326290
P1476titleErlotinib monotherapy in patients with advanced non-small cell lung cancer: an effective approach with low toxicity
P478volume28

Reverse relations

cites work (P2860)
Q35263024Erlotinib 'dosing-to-rash': a phase II intrapatient dose escalation and pharmacologic study of erlotinib in previously treated advanced non-small cell lung cancer
Q37676970Nuclear EGFR as novel therapeutic target: insights into nuclear translocation and function

Search more.